Navigation Links
Scripps Research and Vanderbilt to launch joint institute
Date:1/13/2011

LA JOLLA, CA, AND NASHVILLE, TN January 13, 2010 The Scripps Research Institute and Vanderbilt University have formed a partnership to advance science at the interface of chemistry and medicine, the institutions announced today.

The Human Chemical Sciences Institute will encompass research and training activities at Scripps Research on its San Diego, California, and Jupiter, Florida, campuses, and at the Vanderbilt Institute for Chemical Biology (VICB) and Vanderbilt University School of Medicine in Nashville, Tennessee.

Special emphasis will be devoted to the areas of drug discovery, personalized medicine and metabolomics, the latter referring to the study of small molecule metabolites that could lead to diagnostic and therapeutic biomarkers.

"The chemical sciences provide the basis for current understanding of human physiology, pharmacology and drug discovery," said Scripps Research President Richard A. Lerner, M.D. "Yet there remains a gulf between academic research in chemistry and medical practice. The time is right for a new initiative that seeks to accelerate the understanding of human chemistry in health and disease."

"The goal of the Human Chemical Sciences Institute is to impact medical care through a chemistry-focused view of the human metabolic state, disease and the effects of treatment," said Jeffrey Balser, M.D., Ph.D., vice chancellor for health affairs and dean of Vanderbilt University School of Medicine.

The new institute will combine Scripps Research's expertise as a powerhouse in synthetic and bioorganic chemistry, the strength of both institutions at the interface of chemistry and biology, and Vanderbilt's recognized leadership in drug discovery, genomics, bioinformatics, and medical systems innovation. Seed funding from both Scripps Research and Vanderbilt will be used to promote cross-institutional and cross-disciplinary research partnerships that capitalize upon these strengths.

The three focus areas will be led by the following individuals:

  • Metabolomics Gary Siuzdak, Ph.D., Senior Director of the Center for Metabolomics at Scripps California, and Alex Brown, Ph.D., VICB associate director of Systems Analysis at Vanderbilt;
  • Drug Discovery Craig Lindsley, Ph.D., director of Medicinal Chemistry for the Vanderbilt Program in Drug Discovery, and Patrick Griffin, Ph.D., chair of the Department of Molecular Therapeutics at Scripps Florida; and
  • Personalized Medicine Daniel Salomon, M.D., associate professor in the Department of Molecular and Experimental Medicine at Scripps California, and Dan Roden, M.D., assistant vice chancellor for Personalized Medicine at Vanderbilt.

Natural Partners

Vanderbilt and Scripps Research participants view the two institutions as natural partners. In addition to their overlapping research strengths, both institutions direct substantial effort toward translational science, which seeks to advance discoveries in laboratory research to the clinical setting. Both Vanderbilt and Scripps Research have received Clinical and Translational Science Awards from the National Institutes of Health (NIH) to improve human health through clinical and translational research, and both are major players in the search for potential drugs and biomarkers through the NIH-supported Molecular Libraries Probe Centers Network.

All of these efforts are laying the foundation for personalized medicine, for example, by clarifying how variations in the genetic and chemical makeup among individuals can affect their response to nutrients, drugs and compounds in the environment.

Training will be an important part of the partnership. The goal is to educate new kinds of scientists and physicians who are deeply grounded in the principles and practice of modern chemistry.


'/>"/>

Contact: Mika Ono
mikaono@scripps.edu
858-784-2052
Scripps Research Institute
Source:Eurekalert

Related biology news :

1. Scripps Research chemist devises new method to quantify protein changes
2. Scripps Research scientists identify key interaction in hepatitis C virus
3. Scripps Research scientist uncovers switch controlling protein production
4. Scripps Research scientists show prions mutate and adapt to host environment
5. Scripps scientists see the light in bizarre bioluminescent snail
6. Scripps Research scientists redefine the role of plasma cells in the immune system
7. Judy and J. John Goodman give $50,000 gift to Scripps Florida
8. New Scripps Florida scientist awarded pair of unconventional grants
9. Scripps Research scientists identify new mechanism regulating daily biological rhythms
10. Scripps Research team watches formation of cells protein factories for first time
11. Landenberger Foundation awards grant to Scripps Florida scientist to study HIV
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/21/2016)... 2016 NuData Security announced today that Randy ... principal product architect and that Jon Cunningham ... development. Both will report directly to Christopher ... reflect NuData,s strategic growth in its product and ... demand and customer focus values. ...
(Date:6/9/2016)... Finland , June 9, 2016 ... National Police deploy Teleste,s video security solution to ensure the ... France during the major tournament ... data communications systems and services, announced today that its video ... Prefecture to back up public safety across the ...
(Date:6/2/2016)... , June 2, 2016 Perimeter ... Platforms, Unmanned Systems, Physical Infrastructure, Support & Other Service  ... visiongain offers comprehensive analysis of the global ... market will generate revenues of $17.98 billion in 2016. ... DVTEL Inc, a leader in software and hardware technologies ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical journal ... Their findings are the subject of a new article on the Surviving Mesothelioma website. ... the blood, lung fluid or tissue of mesothelioma patients that can help point doctors ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... Calif. , June 23, 2016  The Prostate Cancer Foundation ... increasingly precise treatments and faster cures for prostate cancer. Members of the Class ... across 15 countries. Read More About the Class of ... ... ...
(Date:6/23/2016)... ... 23, 2016 , ... STACS DNA Inc., the sample tracking software company, today ... Laboratory, has joined STACS DNA as a Field Application Specialist. , “I am ... and COO of STACS DNA. “In further expanding our capacity as a scientific integrator, ...
Breaking Biology Technology: